<?xml version="1.0" encoding="UTF-8"?>
<p id="p0570">Cinanserin was considered an inhibitor of SARS-CoV (
 <italic>IC</italic>
 <sub>50</sub> = 4.92 μM) 
 <xref rid="b0800" ref-type="bibr">[160]</xref>, but the inhibition of the purified SARS-CoV-2 Mpro was not high (
 <italic>IC</italic>
 <sub>50</sub> = 125 μM), so as only moderate inhibition was observed against SARS-CoV-2 with an 
 <italic>EC</italic>
 <sub>50</sub> of 20.61 μM from qRT-PCR analysis 
 <xref rid="b0620" ref-type="bibr">[124]</xref>. The cmpd-26, an analogue of cinanserin, showed an IC
 <sub>50</sub> of 1.06 μM for SARS-CoV Mpro 
 <xref rid="b0795" ref-type="bibr">[159]</xref>.
</p>
